Completed NA INTERVENTIONAL 3-arm NCT00432809

Advanced Medical Therapy Versus Advanced Medical Therapy Plus Bariatric Surgery for the Resolution of Type 2 Diabetes

STAMPEDE: Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently

Sponsor: Ethicon Endo-Surgery

Conditions Diabetes Mellitus, Type 2 Obesity

Interventions Gastric bypass Sleeve Gastrectomy

Updated 7 times since 2017 Last updated: Jul 18, 2017 Started: Feb 28, 2007 Primary completion: Feb 29, 2016 Completion: Sep 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00432809, this NA trial focuses on Diabetes Mellitus, Type 2 and Obesity and remains completed. Sponsored by Ethicon Endo-Surgery, it has been updated 7 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2021 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Dec 2021 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Sep 2017 — Jun 2018 [monthly]

Completed NA

Phase: PHASE4 → NA
Jan 2017 — Sep 2017 [monthly]

Completed PHASE4

First recorded

Feb 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ethicon Endo-Surgery
LifeScan
The Cleveland Clinic

Data source: The Cleveland Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cleveland, United States